Cargando…

Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire

AIM: To measure the level of agreement and application of 10 international recommendations for treating rheumatoid arthritis (RA) to a target of remission/low disease activity. METHODS: A 10-point Likert scale (1=fully disagree, 10=fully agree) measured the level of agreement with each of 10 recomme...

Descripción completa

Detalles Bibliográficos
Autores principales: Haraoui, Boulos, Smolen, Josef S, Aletaha, Daniel, Breedveld, Ferdinand C, Burmester, Gerd, Codreanu, Catalin, Da Silva, José Pereira, de Wit, Maarten, Dougados, Maxime, Durez, Patrick, Emery, Paul, Fonseca, João Eurico, Gibofsky, Allan, Gomez-Reino, Juan, Graninger, Winfried, Hamuryudan, Vedat, Jannaut Peῆa, Maria José, Kalden, Joachim, Kvien, Tore K, Laurindo, Ieda, Martin-Mola, Emilio, Montecucco, Carlomaurizio, Santos Moreno, Pedro, Pavelka, Karel, Poor, Gyula, Cardiel, Mario H, Stanislawska-Biernat, Ewa, Takeuchi, Tsutomu, van der Heijde, Désirée
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273732/
https://www.ncbi.nlm.nih.gov/pubmed/21803747
http://dx.doi.org/10.1136/ard.2011.154179
_version_ 1782222959710044160
author Haraoui, Boulos
Smolen, Josef S
Aletaha, Daniel
Breedveld, Ferdinand C
Burmester, Gerd
Codreanu, Catalin
Da Silva, José Pereira
de Wit, Maarten
Dougados, Maxime
Durez, Patrick
Emery, Paul
Fonseca, João Eurico
Gibofsky, Allan
Gomez-Reino, Juan
Graninger, Winfried
Hamuryudan, Vedat
Jannaut Peῆa, Maria José
Kalden, Joachim
Kvien, Tore K
Laurindo, Ieda
Martin-Mola, Emilio
Montecucco, Carlomaurizio
Santos Moreno, Pedro
Pavelka, Karel
Poor, Gyula
Cardiel, Mario H
Stanislawska-Biernat, Ewa
Takeuchi, Tsutomu
van der Heijde, Désirée
author_facet Haraoui, Boulos
Smolen, Josef S
Aletaha, Daniel
Breedveld, Ferdinand C
Burmester, Gerd
Codreanu, Catalin
Da Silva, José Pereira
de Wit, Maarten
Dougados, Maxime
Durez, Patrick
Emery, Paul
Fonseca, João Eurico
Gibofsky, Allan
Gomez-Reino, Juan
Graninger, Winfried
Hamuryudan, Vedat
Jannaut Peῆa, Maria José
Kalden, Joachim
Kvien, Tore K
Laurindo, Ieda
Martin-Mola, Emilio
Montecucco, Carlomaurizio
Santos Moreno, Pedro
Pavelka, Karel
Poor, Gyula
Cardiel, Mario H
Stanislawska-Biernat, Ewa
Takeuchi, Tsutomu
van der Heijde, Désirée
author_sort Haraoui, Boulos
collection PubMed
description AIM: To measure the level of agreement and application of 10 international recommendations for treating rheumatoid arthritis (RA) to a target of remission/low disease activity. METHODS: A 10-point Likert scale (1=fully disagree, 10=fully agree) measured the level of agreement with each of 10 recommendations. A 4-point Likert scale (never, not very often, very often, always) assessed the degree to which each recommendation was being applied in current daily practice. If respondents answered ‘never’ or ‘not very often’, they were asked whether they would change their practice according to the particular recommendation. RESULTS: A total of 1901 physicians representing 34 countries participated. Both agreement with and application of recommendations was high. With regard to application of recommendations in daily practice, the majority of responses were ‘always’ and ‘very often’. A significant percentage of participants who were currently not applying these recommendations in clinical practice were willing to change their practice according to the recommendations. CONCLUSION: The results of this survey demonstrated great support of ‘Treating RA to Target’ recommendations among the international rheumatology community. Additional efforts may be needed to encourage application of the recommendations among certain clinicians who are resistant to changing their practice.
format Online
Article
Text
id pubmed-3273732
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BMJ Group
record_format MEDLINE/PubMed
spelling pubmed-32737322012-02-16 Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire Haraoui, Boulos Smolen, Josef S Aletaha, Daniel Breedveld, Ferdinand C Burmester, Gerd Codreanu, Catalin Da Silva, José Pereira de Wit, Maarten Dougados, Maxime Durez, Patrick Emery, Paul Fonseca, João Eurico Gibofsky, Allan Gomez-Reino, Juan Graninger, Winfried Hamuryudan, Vedat Jannaut Peῆa, Maria José Kalden, Joachim Kvien, Tore K Laurindo, Ieda Martin-Mola, Emilio Montecucco, Carlomaurizio Santos Moreno, Pedro Pavelka, Karel Poor, Gyula Cardiel, Mario H Stanislawska-Biernat, Ewa Takeuchi, Tsutomu van der Heijde, Désirée Ann Rheum Dis Clinical and Epidemiological Research AIM: To measure the level of agreement and application of 10 international recommendations for treating rheumatoid arthritis (RA) to a target of remission/low disease activity. METHODS: A 10-point Likert scale (1=fully disagree, 10=fully agree) measured the level of agreement with each of 10 recommendations. A 4-point Likert scale (never, not very often, very often, always) assessed the degree to which each recommendation was being applied in current daily practice. If respondents answered ‘never’ or ‘not very often’, they were asked whether they would change their practice according to the particular recommendation. RESULTS: A total of 1901 physicians representing 34 countries participated. Both agreement with and application of recommendations was high. With regard to application of recommendations in daily practice, the majority of responses were ‘always’ and ‘very often’. A significant percentage of participants who were currently not applying these recommendations in clinical practice were willing to change their practice according to the recommendations. CONCLUSION: The results of this survey demonstrated great support of ‘Treating RA to Target’ recommendations among the international rheumatology community. Additional efforts may be needed to encourage application of the recommendations among certain clinicians who are resistant to changing their practice. BMJ Group 2011-07-29 /pmc/articles/PMC3273732/ /pubmed/21803747 http://dx.doi.org/10.1136/ard.2011.154179 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Clinical and Epidemiological Research
Haraoui, Boulos
Smolen, Josef S
Aletaha, Daniel
Breedveld, Ferdinand C
Burmester, Gerd
Codreanu, Catalin
Da Silva, José Pereira
de Wit, Maarten
Dougados, Maxime
Durez, Patrick
Emery, Paul
Fonseca, João Eurico
Gibofsky, Allan
Gomez-Reino, Juan
Graninger, Winfried
Hamuryudan, Vedat
Jannaut Peῆa, Maria José
Kalden, Joachim
Kvien, Tore K
Laurindo, Ieda
Martin-Mola, Emilio
Montecucco, Carlomaurizio
Santos Moreno, Pedro
Pavelka, Karel
Poor, Gyula
Cardiel, Mario H
Stanislawska-Biernat, Ewa
Takeuchi, Tsutomu
van der Heijde, Désirée
Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire
title Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire
title_full Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire
title_fullStr Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire
title_full_unstemmed Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire
title_short Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire
title_sort treating rheumatoid arthritis to target: multinational recommendations assessment questionnaire
topic Clinical and Epidemiological Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273732/
https://www.ncbi.nlm.nih.gov/pubmed/21803747
http://dx.doi.org/10.1136/ard.2011.154179
work_keys_str_mv AT haraouiboulos treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT smolenjosefs treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT aletahadaniel treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT breedveldferdinandc treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT burmestergerd treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT codreanucatalin treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT dasilvajosepereira treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT dewitmaarten treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT dougadosmaxime treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT durezpatrick treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT emerypaul treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT fonsecajoaoeurico treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT gibofskyallan treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT gomezreinojuan treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT graningerwinfried treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT hamuryudanvedat treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT jannautpeēamariajose treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT kaldenjoachim treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT kvientorek treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT laurindoieda treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT martinmolaemilio treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT montecuccocarlomaurizio treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT santosmorenopedro treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT pavelkakarel treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT poorgyula treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT cardielmarioh treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT stanislawskabiernatewa treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT takeuchitsutomu treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire
AT vanderheijdedesiree treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire